Search results: Sage Journals

Restricted accessResearch articleFirst published July, 1995

The Drug Regulatory Process of the Republic of China — Taiwan's Experiences in Bioavailability and Bioequivalence

Oliver Yoa-Pu Hu, Mei-Ling Hsiao, Li-Ling Liu

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published January, 1999

The Regulatory Approval Process of Animal Drugs

Stephen J. Gilbride, Michael J. McGowan

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published October, 1998

An Overview of the Regulatory Approval Process in Drug Development

Shein-Chung Chow, Annpey Pong

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published October, 1997

Good Statistics Practice in the Drug Development and Regulatory Approval Process

Shein-Chung Chow

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published July, 1997

The Regulatory Affairs Professional in the “Hot Seat” in the Drug Development Process

Loren L. Miller, David M. Cocchetto

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published May, 2007

A Comparison of the Drug Review Process at Five International Regulatory Agencies

Mayu Hirako, Neil McAuslane, Sam Salek [...]

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published October, 1997

The Various Regulatory Clinical Development Pathways to Obtain Marketing Approval

Thomas A. Hayes, D. P. Gangi

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published April, 2026

Novel Deiodinase 2-Selective Inhibitors—Possible Reference Substances for Regulatory In Vitro Tests for Endocrine Disruptors and Drugs Targeting T3-Dependent Processes

Caroline Frädrich, Niklas Wiese, Yiming Zhang [...]

Thyroid®

Restricted accessResearch articleFirst published October, 1995

Can the Drug Regulatory Process be Made More Efficient? — A View from the Medicines Control Agency

David Jefferys

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published January, 2002

Patient-Reported Outcomes: The Example of Health-Related Quality of Life—A European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process

Olivier Chassany, Pierre Sagnier, Patrick Marquis [...]

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published July, 1995

The Drug Regulatory Process of the Republic of China — Taiwan's Experiences in Bioavailability and Bioequivalence

Oliver Yoa-Pu Hu, Mei-Ling Hsiao, Li-Ling Liu

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published January, 1999

The Regulatory Approval Process of Animal Drugs

Stephen J. Gilbride, Michael J. McGowan

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published October, 1998

An Overview of the Regulatory Approval Process in Drug Development

Shein-Chung Chow, Annpey Pong

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published October, 1997

Good Statistics Practice in the Drug Development and Regulatory Approval Process

Shein-Chung Chow

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published July, 1997

The Regulatory Affairs Professional in the “Hot Seat” in the Drug Development Process

Loren L. Miller, David M. Cocchetto

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published May, 2007

A Comparison of the Drug Review Process at Five International Regulatory Agencies

Mayu Hirako, Neil McAuslane, Sam Salek [...]

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published October, 1997

The Various Regulatory Clinical Development Pathways to Obtain Marketing Approval

Thomas A. Hayes, D. P. Gangi

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published April, 2026

Novel Deiodinase 2-Selective Inhibitors—Possible Reference Substances for Regulatory In Vitro Tests for Endocrine Disruptors and Drugs Targeting T3-Dependent Processes

Caroline Frädrich, Niklas Wiese, Yiming Zhang [...]

Thyroid®

Restricted accessResearch articleFirst published October, 1995

Can the Drug Regulatory Process be Made More Efficient? — A View from the Medicines Control Agency

David Jefferys

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published January, 2002

Patient-Reported Outcomes: The Example of Health-Related Quality of Life—A European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process

Olivier Chassany, Pierre Sagnier, Patrick Marquis [...]

Therapeutic Innovation & Regulatory Science